[go: up one dir, main page]

PL1906939T3 - Zastosowanie częściowo zobojętnianego, anionowego kopolimeru (met)akrylanowego jako powłoki do wytwarzania postaci leku z uwalnianiem substancji czynnej przy obniżonych wartościach pH - Google Patents

Zastosowanie częściowo zobojętnianego, anionowego kopolimeru (met)akrylanowego jako powłoki do wytwarzania postaci leku z uwalnianiem substancji czynnej przy obniżonych wartościach pH

Info

Publication number
PL1906939T3
PL1906939T3 PL06724062.2T PL06724062T PL1906939T3 PL 1906939 T3 PL1906939 T3 PL 1906939T3 PL 06724062 T PL06724062 T PL 06724062T PL 1906939 T3 PL1906939 T3 PL 1906939T3
Authority
PL
Poland
Prior art keywords
meth
anionic
coating
values
production
Prior art date
Application number
PL06724062.2T
Other languages
English (en)
Inventor
Hans-Ulrich Petereit
Manfred Assmus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL1906939T3 publication Critical patent/PL1906939T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06724062.2T 2005-07-12 2006-04-05 Zastosowanie częściowo zobojętnianego, anionowego kopolimeru (met)akrylanowego jako powłoki do wytwarzania postaci leku z uwalnianiem substancji czynnej przy obniżonych wartościach pH PL1906939T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005032806A DE102005032806A1 (de) 2005-07-12 2005-07-12 Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten

Publications (1)

Publication Number Publication Date
PL1906939T3 true PL1906939T3 (pl) 2016-12-30

Family

ID=37507688

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06724062.2T PL1906939T3 (pl) 2005-07-12 2006-04-05 Zastosowanie częściowo zobojętnianego, anionowego kopolimeru (met)akrylanowego jako powłoki do wytwarzania postaci leku z uwalnianiem substancji czynnej przy obniżonych wartościach pH

Country Status (15)

Country Link
US (1) US7932258B2 (pl)
EP (1) EP1906939B1 (pl)
JP (1) JP5193036B2 (pl)
KR (1) KR101325901B1 (pl)
CN (1) CN101193627A (pl)
BR (1) BRPI0612878A2 (pl)
CA (1) CA2609439C (pl)
DE (1) DE102005032806A1 (pl)
ES (1) ES2588173T3 (pl)
HU (1) HUE028344T2 (pl)
IL (1) IL186553A0 (pl)
MX (1) MX290450B (pl)
PL (1) PL1906939T3 (pl)
SI (1) SI1906939T1 (pl)
WO (1) WO2007006353A2 (pl)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP5228359B2 (ja) * 2007-04-12 2013-07-03 ニプロ株式会社 主薬粒子及びその製造方法ならびに口腔内崩壊錠
KR101443943B1 (ko) * 2007-05-07 2014-10-07 에보니크 룀 게엠베하 가속된 약물 방출을 갖는 장용 코팅을 포함하는 고체 투여 형태
WO2009049160A1 (en) * 2007-10-12 2009-04-16 Takeda Pharmaceuticals North America Methods of treating gastrointestinal disorders independent of the intake of food
AU2009224254A1 (en) * 2008-03-11 2009-09-17 Takeda Pharmaceutical Company Limited Orally-disintegrating solid preparation
US8834845B2 (en) * 2009-04-02 2014-09-16 Innotere Gmbh Bioactive bone cement and method for its production
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
PL2456424T3 (pl) 2009-07-22 2013-12-31 Gruenenthal Gmbh Stabilizowana przed utlenianiem odporna na naruszenie postać dawkowania
PE20131102A1 (es) 2010-09-02 2013-10-12 Gruenenthal Chemie Forma de dosificacion resistente a manipulacion que comprende una sal inorganica
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
NO2736497T3 (pl) 2011-07-29 2018-01-20
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
WO2013035081A2 (de) 2011-09-07 2013-03-14 JÄNISCH, Melisa Optimale formulierung zur freisetzung eines wirkstoffes im dickdarm
WO2013045352A1 (de) 2011-09-30 2013-04-04 Basf Se Verfahren zur herstellung von festen pigmenthaltigen filmüberzugsmitteln in form von granulaten auf basis von magensaftresistenten filmbildnern für pharmazeutische dosierungsformen
DK2838512T3 (en) * 2012-04-18 2018-11-19 Gruenenthal Gmbh MANIPULATED AND DOSAGE DUMPED PHARMACEUTICAL DOSAGE FORM
JOP20200144A1 (ar) 2012-04-30 2017-06-16 Tillotts Pharma Ag تركيبة عقار ذو إطلاق متأخر
CN102846386B (zh) * 2012-09-19 2015-02-25 四川大学 智能可控释放抗菌成分的牙种植体及制备方法
AU2014273227B2 (en) 2013-05-29 2019-08-15 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
BR112016000194A8 (pt) 2013-07-12 2019-12-31 Gruenenthal Gmbh forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
BR122020013726B1 (pt) * 2013-10-29 2022-11-01 Tillotts Pharma Ag Formulação de droga de liberação retardada
WO2015078891A1 (en) 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Preparation of a powdery pharmaceutical composition by means of cryo-milling
AU2015341070B2 (en) * 2014-10-28 2019-11-21 Merck Patent Gmbh Preparation of nanoparticles-releasing enteric microparticles
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN106317426A (zh) * 2016-08-19 2017-01-11 湖州展望天明药业有限公司 一种可再分散的聚丙烯酸树脂粉末及其制备方法
EP3662901B1 (en) 2018-12-07 2025-01-01 Tillotts Pharma AG Delayed release drug formulation comprising an outerlayer with an enzymatically degradable polymer, its composition and its method of manufacturing
EP3662895A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG A process for manufacturing reducing sugar-free 5-asa tablet cores
EP3662898A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine
EP3662900A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
EP3662902B1 (en) 2018-12-07 2024-07-31 Tillotts Pharma AG Colonic drug delivery formulation
JP7624444B2 (ja) 2019-12-11 2025-01-30 エボニック オペレーションズ ゲーエムベーハー 病気の治療又は予防において使用するための剤形
MX2022007160A (es) 2019-12-11 2022-07-11 Evonik Operations Gmbh Forma de dosificacion para usarse en el tratamiento o prevencion de una enfermedad.
US20230000780A1 (en) 2019-12-11 2023-01-05 Evonik Operations Gmbh Dosage form comprising an alkaline agent and an enteric coating layer
KR20220128362A (ko) 2019-12-27 2022-09-20 에벨로 바이오사이언시즈, 인크. 박테리아 및 미생물 세포외 소포체를 함유하는 고체 투여 형태
TW202140051A (zh) 2020-01-17 2021-11-01 美商艾弗洛生物科技股份有限公司 具有改善的崩散譜之固體劑型
JP2023522018A (ja) 2020-04-17 2023-05-26 エヴェロ バイオサイエンシズ，インコーポレーテッド 改善された崩壊プロファイルを有する固形剤形
CA3192766A1 (en) 2020-09-18 2022-03-24 Syed Altaf Solid dosage forms of bacteria
WO2022061123A1 (en) 2020-09-21 2022-03-24 Evelo Biosciences, Inc. Solid dosage forms with improved disintegration profiles
CN116648253A (zh) 2020-10-29 2023-08-25 伊夫罗生物科学公司 包含螺旋藻组分的组合物
WO2022125005A1 (en) * 2020-12-08 2022-06-16 Santa Farma Ilac Sanayii A. S. Stable sustained release compositions of acemetacine
US20240058271A1 (en) 2020-12-14 2024-02-22 Kevin Huynh Extracellular vesicle preparations
WO2022140396A1 (en) 2020-12-22 2022-06-30 Evelo Biosciences, Inc. Compositions comprising animal hemoglobin
KR20230137968A (ko) 2021-01-26 2023-10-05 에벨로 바이오사이언시즈, 인크. 프레보텔라 세포외 소포체 제제
EP4297762A1 (en) 2021-02-26 2024-01-03 Evelo Biosciences, Inc. Compositions and methods for reducing cytokine expression
WO2022187578A1 (en) 2021-03-05 2022-09-09 Evelo Biosciences, Inc. Solid dosage forms
US20250073285A1 (en) 2021-04-08 2025-03-06 Evelo Biosciences, Inc. Pharmaceutical composition containing bacteria
WO2022221183A1 (en) 2021-04-12 2022-10-20 Evelo Biosciences, Inc. Fournierella extracellular vesicle preparations
WO2022251166A2 (en) 2021-05-25 2022-12-01 Evelo Biosciences, Inc. Bacterial compositions comprising soy hemoglobin
WO2023049268A1 (en) 2021-09-24 2023-03-30 Evelo Biosciences, Inc. Solid dosage forms containing bacteria and microbial extracellular vesicles
WO2023114300A1 (en) 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Fournierella massiliensis bacteria extracellular vesicle preparations
WO2023114295A1 (en) 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Veillonella parvula bacteria extracellular vesicle preparations
WO2023114293A1 (en) 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Extracellular vesicle assays
WO2023146843A1 (en) 2022-01-25 2023-08-03 Evelo Biosciences, Inc. Extracellular vesicle compositions and methods of use
WO2023183396A1 (en) 2022-03-22 2023-09-28 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2023200837A1 (en) 2022-04-13 2023-10-19 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2023239728A1 (en) 2022-06-07 2023-12-14 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola extracellular vesicles
WO2024102226A1 (en) 2022-10-14 2024-05-16 Evelo Biosciences, Inc. Methods for assaying drug substances and drug products by using cell lines with nf-kb- inducible reporter genes
WO2025082974A1 (en) 2023-10-16 2025-04-24 Bioprojet Pharma New formulations of pitolisant and methods of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT93637A (pt) 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
DE19626045C2 (de) * 1996-06-28 1998-12-03 Klinge Co Chem Pharm Fab Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
US6174548B1 (en) * 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
WO2000033821A1 (en) * 1998-12-07 2000-06-15 Bristol-Myers Squibb Company Enteric coated pravastatin bead formulation
WO2002096394A2 (en) * 2001-05-30 2002-12-05 Euro-Celtique S.A. Pharmaceutical composition containing stool softener such as polaxamer and enteric coated particles of bisacodyl
DE10208335A1 (de) 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
DE10260919A1 (de) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
DE102005007059A1 (de) * 2005-02-15 2006-08-24 Röhm GmbH & Co. KG Teilneutralisiertes anionisches (Meth)acrylat-Copolymer
PL2051704T3 (pl) 2006-08-18 2012-09-28 Evonik Roehm Gmbh Kompozycja farmaceutyczna o kontrolowanym dostarczaniu substancji aktywnej o dobrej rozpuszczalności

Also Published As

Publication number Publication date
CN101193627A (zh) 2008-06-04
KR20080024200A (ko) 2008-03-17
DE102005032806A1 (de) 2007-01-18
CA2609439C (en) 2013-10-29
WO2007006353A2 (de) 2007-01-18
US20080200482A1 (en) 2008-08-21
SI1906939T1 (sl) 2016-10-28
KR101325901B1 (ko) 2013-11-07
EP1906939B1 (de) 2016-06-01
US7932258B2 (en) 2011-04-26
MX2007015954A (es) 2008-10-27
CA2609439A1 (en) 2007-01-18
IL186553A0 (en) 2008-01-20
MX290450B (es) 2011-09-23
ES2588173T3 (es) 2016-10-31
BRPI0612878A2 (pt) 2010-11-30
JP2009501163A (ja) 2009-01-15
HUE028344T2 (en) 2016-12-28
EP1906939A2 (de) 2008-04-09
WO2007006353A3 (de) 2007-04-12
JP5193036B2 (ja) 2013-05-08

Similar Documents

Publication Publication Date Title
PL1906939T3 (pl) Zastosowanie częściowo zobojętnianego, anionowego kopolimeru (met)akrylanowego jako powłoki do wytwarzania postaci leku z uwalnianiem substancji czynnej przy obniżonych wartościach pH
WO2008003958A3 (en) Fused pyrimido compounds
IL250858B (en) A tetracycline compound, a pharmaceutical composition comprising the tetracycline compound, and the tetracycline compound or the pharmaceutical composition for treating a tetracycline responsive state
GEP20125410B (en) Solid preparation comprising alogliptin and pioglitazone
WO2006131721A3 (en) Topical ungual formulations
TW200833372A (en) Use of (meth)acrylate copolymers in delayed-release pharmaceutical forms for decreasing the influence of ethanol on the release of active compound
WO2007127263A3 (en) Therapeutic uses of urolithins
USD629114S1 (en) Set of bandages for a healing wound
WO2009084024A3 (en) A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof
WO2007025613A3 (en) Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain
EP2035398B8 (en) Immobilized 1,2-benzisothiazolin-3-one
WO2006084164A8 (en) Gastric retention and controlled release delivery system
WO2007052299A3 (en) Controlled release formulation
WO2009040666A3 (en) Treatment of graft-versus-host disease
WO2009013019A3 (en) Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions
EG25586A (en) Coated fertiliser with a controlled release of active ingredients, and method for the production thereof
WO2007130822A3 (en) Mglur5 modulators iii
EP2180024A4 (en) HYDROPHILIC FILM-FORMING COMPOSITION, SPRAYING COMPOSITION AND HYDROPHILIC ELEMENT THEREWITH
EP2048141A4 (en) OPTICALLY PURE DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OR PREVENTION OF VIRUSES
GB2460590B (en) Adjuvant composition, agrochemical spray aqueous solution containing the same and control method using the same
EP2010570B8 (en) Therapy against cathepsin s
WO2008068299A3 (en) Hydrobromide salt of an anti-hiv compound
WO2008073863A3 (en) Preparation and utility of substituted allylamines
WO2008157563A3 (en) Deuterium-enriched clopidogrel
USD640006S1 (en) Fingernail coating application assistance device